EPS Bio Technology Corp. (TPEX:4183)
Taiwan
· Delayed Price · Currency is TWD 14.10
-0.10 (-0.70%)
Apr 29, 2026, 1:30 PM CST
EPS Bio Technology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 499.7 | 451.08 | 470.17 | 463.45 | 480.28 | Upgrade
|
| Revenue Growth (YoY) | 10.78% | -4.06% | 1.45% | -3.50% | 0.56% | Upgrade
|
| Cost of Revenue | 412.66 | 354.82 | 354.46 | 356.04 | 359.61 | Upgrade
|
| Gross Profit | 87.04 | 96.27 | 115.71 | 107.42 | 120.67 | Upgrade
|
| Selling, General & Admin | 59.04 | 59.32 | 57.41 | 57.92 | 54.13 | Upgrade
|
| Research & Development | 34.5 | 33.43 | 33.22 | 30.88 | 32.28 | Upgrade
|
| Operating Expenses | 96.14 | 90.87 | 90.79 | 91.4 | 87.61 | Upgrade
|
| Operating Income | -9.1 | 5.4 | 24.92 | 16.01 | 33.06 | Upgrade
|
| Interest Expense | -1.9 | -2.05 | -2.14 | -2.13 | -2.18 | Upgrade
|
| Interest & Investment Income | 0.81 | 2.75 | 2.58 | 0.22 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 11.35 | 0.97 | 13.15 | -7.55 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.51 | 0.36 | 0.39 | 0.21 | 0.11 | Upgrade
|
| EBT Excluding Unusual Items | -9.67 | 17.81 | 26.72 | 27.46 | 23.52 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.26 | - | - | Upgrade
|
| Pretax Income | -9.67 | 17.81 | 26.46 | 27.46 | 23.52 | Upgrade
|
| Income Tax Expense | -1.8 | 0.5 | 5.47 | 2.1 | 4.88 | Upgrade
|
| Net Income | -7.87 | 17.31 | 20.99 | 25.36 | 18.64 | Upgrade
|
| Net Income to Common | -7.87 | 17.31 | 20.99 | 25.36 | 18.64 | Upgrade
|
| Net Income Growth | - | -17.54% | -17.24% | 36.06% | -41.20% | Upgrade
|
| Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 24 | Upgrade
|
| Shares Change (YoY) | -0.07% | -0.08% | -0.10% | 0.03% | -0.13% | Upgrade
|
| EPS (Basic) | -0.33 | 0.73 | 0.88 | 1.07 | 0.78 | Upgrade
|
| EPS (Diluted) | -0.33 | 0.73 | 0.88 | 1.06 | 0.78 | Upgrade
|
| EPS Growth | - | -17.36% | -16.98% | 35.90% | -41.35% | Upgrade
|
| Free Cash Flow | -21.76 | -46.24 | 45.69 | -9.96 | 20.34 | Upgrade
|
| Free Cash Flow Per Share | -0.91 | -1.94 | 1.91 | -0.42 | 0.85 | Upgrade
|
| Dividend Per Share | - | 0.670 | 0.800 | 0.980 | 0.700 | Upgrade
|
| Dividend Growth | - | -16.25% | -18.37% | 40.00% | -41.67% | Upgrade
|
| Gross Margin | 17.42% | 21.34% | 24.61% | 23.18% | 25.12% | Upgrade
|
| Operating Margin | -1.82% | 1.20% | 5.30% | 3.45% | 6.88% | Upgrade
|
| Profit Margin | -1.57% | 3.84% | 4.46% | 5.47% | 3.88% | Upgrade
|
| Free Cash Flow Margin | -4.35% | -10.25% | 9.72% | -2.15% | 4.23% | Upgrade
|
| EBITDA | 6.29 | 15.66 | 35.9 | 28.72 | 47.01 | Upgrade
|
| EBITDA Margin | 1.26% | 3.47% | 7.64% | 6.20% | 9.79% | Upgrade
|
| D&A For EBITDA | 15.38 | 10.26 | 10.98 | 12.71 | 13.96 | Upgrade
|
| EBIT | -9.1 | 5.4 | 24.92 | 16.01 | 33.06 | Upgrade
|
| EBIT Margin | -1.82% | 1.20% | 5.30% | 3.45% | 6.88% | Upgrade
|
| Effective Tax Rate | - | 2.80% | 20.67% | 7.64% | 20.76% | Upgrade
|
| Revenue as Reported | 499.7 | - | - | - | - | Upgrade
|
| Advertising Expenses | - | 3.03 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.